Ampio Pharmaceuticals Is Waking Up From Its COVID-19 Slumber, Approaching Potential Approval For Severe OAK
Seeking Alpha,
Summary Ampio’s delayed pivotal phase 3 trial for severe OAK to resume. Strong hints of Ampion showing efficacy in COVID-19.
Summary Ampio’s delayed pivotal phase 3 trial for severe OAK to resume. Strong hints of Ampion showing efficacy in COVID-19.